Cargando…
Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
Adoptive immunotherapy using immune effector cells has revolutionized cancer treatments with approval of two autologous chimeric antigen receptor (CAR) T cell therapies by the US FDA. Clinical trials using natural killer (NK) cell-based adoptive immunotherapy have been shown to be safe and effective...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974906/ https://www.ncbi.nlm.nih.gov/pubmed/35402797 http://dx.doi.org/10.1097/BS9.0000000000000023 |